GRDX logo

GRIDAI TECHNOLOGIES CORP

GRDXNASDAQ
πŸ† #4361 by market capUS Equity
$5.74β–² $0.12 (+2.14%)
Pre-market Β· at close
πŸ””
Track GRDX
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 2.1%
7dβ–² 7.5%
14dβ–² 37.0%
30dβ–² 79.9%
ytdβ–² 27.8%
1yβ–² 34.7%
🏦Market Cap
$41M
Small Cap
πŸ“ˆRevenue Growth (YoY)
0.0%
Slowing
πŸ“ŠGross Margin
-1532.5%
Thin
πŸ’΅FCF Margin
-5064.9%
Thin
βš–οΈP/S Ratio
259.5x
Expensive
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$5.74 – $5.89
52-Week Range
$1.87 – $6.93
Volume (shares)
737
Avg Volume (shares)
β€”
Shares Outstanding
7.1M
Next Earnings
β€”

Fundamentals Snapshot

Annual Revenue
$36,251
Last Q Revenue
$85,876
P/E Ratio
-1.4
P/S Ratio
259.5x
EPS (TTM)
$-3.19
Dividend Yield
0.00%
Dilution (1yr)
βˆ’11.1%
GRDX logo

GRIDAI TECHNOLOGIES CORP

GRDX
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$36Kβ–² +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$7Mβ–Ό βˆ’54.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$6Mβ–Ό βˆ’38.1% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
4.2Mβ–Ό βˆ’11.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$1Mβ–Ό βˆ’$1M YoY
StockOtter Β· stockotter.space

About GRIDAI TECHNOLOGIES CORP

GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100

Analyst Ratings

β“˜
Consensus
Sell
6 analysts
Strong Buy0
Buy0
Hold3
Sell1
Strong Sell2
Ratings as of Mar 2025

Latest News & Updates

News unavailable.